Should You Buy Gemini Therapeutics (GMTX) Ahead of Earnings? Posted byZacks Equity Research November 10, 2021 Leave a comment on Should You Buy Gemini Therapeutics (GMTX) Ahead of Earnings? Gemini Therapeutics (GMTX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.